Stephens Issues Pessimistic Forecast for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price objective dropped by investment analysts at Stephens from $153.00 to $142.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Stephens’ price target indicates a potential upside of 46.38% from the company’s current price.

Other equities analysts also recently issued research reports about the company. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Finally, StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $133.89.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $97.01 on Wednesday. The stock has a market capitalization of $1.76 billion, a price-to-earnings ratio of 22.20, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.72. The company has a fifty day moving average of $123.94 and a 200-day moving average of $126.50.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, equities research analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Quarry LP acquired a new position in Addus HomeCare during the 3rd quarter worth approximately $28,000. Natixis grew its stake in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC grew its stake in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its stake in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.